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Adult T-cell leukemia (ATL) is an aggressive CD4+CD25+
leukemia with poor prognosis, which usually develops
several decades after HTLV-1 infection. In contrast to
HIV-infection, the treatment of HTLV-1-associated dis-
eases rely on a limited number of drugs. For ATL, combi-
nation therapy with IFN-alpha+AZT has shown clinical
benefit in the non-lymphoma subtypes. Type I IFNs
(IFN-alpha/beta) are essential cytokines with proved anti-
cancer and antiviral action in vitro and in vivo. Nonethe-
less, their mechanisms of action in HTLV-1 infection
remain unclear and a side-by-side comparison of both
type I IFNs has not been performed in ATL. We show, in
short-term culture of primary mononuclear cells from
ATL patients, that both IFNs cause increased apoptosis,
exert an anti-proliferative and antiviral effect, and decrease
pro-inflammatory cytokine levels. However, IFN-beta
treatment was significantly more effective in inhibiting
viral p19 protein levels and lymphoproliferation, as
compared to IFN-alpha. This pronounced effect of IFN-
beta was explained by an induction of a higher number of
known IFN-stimulated genes and antiviral genes by micro-
array analysis (76 vs. 26 genes were selected with p<0.001
and >2-fold difference vs. control). In PBMCs from
healthy donors, ATL patients as well as in HTLV-1-
infected cell lines, both IFNs have comparable activity in
phosphorylating STATs 1 through 5 (PhosFlow), although
phospho-STAT1 levels were up to tenfold higher than
phospho-STAT2 through 5. This predominant STAT1-
mediated antiviral gene signature was confirmed by Inge-
nuity Pathway analysis. In conclusion, our data suggest the
superior antiviral and antiproliferative activity of IFN-beta
vs. IFN-alpha occurs downstream of STAT1 signaling.
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